Charles Schwab’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-226,160
| Closed | -$418K | – | 3741 |
|
|
2023
Q1 | $418K | Hold |
226,160
| – | – | ﹤0.01% | 3006 |
|
|
2022
Q4 | $251K | Sell |
226,160
-16,599
| -7% | -$18.4K | ﹤0.01% | 3146 |
|
|
2022
Q3 | $569K | Sell |
242,759
-116
| -0% | -$272 | ﹤0.01% | 2964 |
|
|
2022
Q2 | $736K | Sell |
242,875
-34,413
| -12% | -$104K | ﹤0.01% | 2911 |
|
|
2022
Q1 | $1.88M | Buy |
277,288
+133,610
| +93% | +$907K | ﹤0.01% | 2663 |
|
|
2021
Q4 | $1.2M | Buy |
143,678
+93
| +0.1% | +$777 | ﹤0.01% | 2841 |
|
|
2021
Q3 | $1.07M | Sell |
143,585
-114,507
| -44% | -$851K | ﹤0.01% | 2854 |
|
|
2021
Q2 | $1.76M | Buy |
258,092
+58,069
| +29% | +$395K | ﹤0.01% | 2758 |
|
|
2021
Q1 | $2.06M | Sell |
200,023
-54,500
| -21% | -$560K | ﹤0.01% | 2654 |
|
|
2020
Q4 | $1.78M | Sell |
254,523
-54,861
| -18% | -$384K | ﹤0.01% | 2621 |
|
|
2020
Q3 | $2.53M | Buy |
309,384
+25,065
| +9% | +$205K | ﹤0.01% | 2415 |
|
|
2020
Q2 | $1.96M | Buy |
284,319
+51,234
| +22% | +$354K | ﹤0.01% | 2436 |
|
|
2020
Q1 | $1.11M | Buy |
233,085
+36,347
| +18% | +$173K | ﹤0.01% | 2466 |
|
|
2019
Q4 | $1.72M | Buy |
196,738
+96,051
| +95% | +$839K | ﹤0.01% | 2460 |
|
|
2019
Q3 | $336K | Buy |
100,687
+4,735
| +5% | +$15.8K | ﹤0.01% | 2942 |
|
|
2019
Q2 | $475K | Buy |
95,952
+1,209
| +1% | +$5.99K | ﹤0.01% | 2833 |
|
|
2019
Q1 | $588K | Buy |
94,743
+10,325
| +12% | +$64.1K | ﹤0.01% | 2703 |
|
|
2018
Q4 | $285K | Buy |
84,418
+8,524
| +11% | +$28.8K | ﹤0.01% | 2952 |
|
|
2018
Q3 | $494K | Buy |
75,894
+27,943
| +58% | +$182K | ﹤0.01% | 2845 |
|
|
2018
Q2 | $368K | Buy |
47,951
+8,103
| +20% | +$62.2K | ﹤0.01% | 2897 |
|
|
2018
Q1 | $891K | Sell |
39,848
-2,681
| -6% | -$59.9K | ﹤0.01% | 2554 |
|
|
2017
Q4 | $543K | Buy |
42,529
+1,092
| +3% | +$13.9K | ﹤0.01% | 2704 |
|
|
2017
Q3 | $646K | Buy |
41,437
+17,218
| +71% | +$268K | ﹤0.01% | 2647 |
|
|
2017
Q2 | $340K | Buy |
24,219
+11,833
| +96% | +$166K | ﹤0.01% | 2821 |
|
|
2017
Q1 | $273K | Buy |
+12,386
| New | +$273K | ﹤0.01% | 2848 |
|